![Carl-Johan Gustafson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl-Johan Gustafson
Chief Executive Officer at NATTARO LABS AB
Profile
Carl-Johan Gustafson is currently the Chief Executive Officer at Nattaro Labs AB and the Director at MVIC AB.
He is a graduate of the University of Lund and has an undergraduate degree from ESCP Europe Campus Paris.
Carl-Johan Gustafson active positions
Companies | Position | Start |
---|---|---|
NATTARO LABS AB | Chief Executive Officer | 2014-12-31 |
MVIC AB
![]() MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Director/Board Member | 2018-12-31 |
Training of Carl-Johan Gustafson
University of Lund | Graduate Degree |
ESCP Europe Campus Paris | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NATTARO LABS AB | Health Technology |
Private companies | 1 |
---|---|
MVIC AB
![]() MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Commercial Services |
- Stock Market
- Insiders
- Carl-Johan Gustafson